81 related articles for article (PubMed ID: 25269647)
21. Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells.
Zhang Y; Liao S; Fan W; Wei W; Wang C; Sun S
Oncol Rep; 2014 Dec; 32(6):2769-76. PubMed ID: 25231320
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells.
Lee CH; Wu YT; Hsieh HC; Yu Y; Yu AL; Chang WW
Biochimie; 2014 Sep; 104():117-26. PubMed ID: 24950183
[TBL] [Abstract][Full Text] [Related]
23. STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening.
Cheng CC; Liao PN; Ho AS; Lim KH; Chang J; Su YW; Chen CG; Chiang YW; Yang BL; Lin HC; Chang YC; Chang CC; Chang YF
J Biomed Sci; 2018 Aug; 25(1):60. PubMed ID: 30068339
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells.
Lee MF; Pan MH; Chiou YS; Cheng AC; Huang H
J Agric Food Chem; 2011 Nov; 59(21):11853-61. PubMed ID: 21942447
[TBL] [Abstract][Full Text] [Related]
25. Progesterone pre-treatment potentiates EGF pathway signaling in the breast cancer cell line ZR-75.
Carvajal A; Espinoza N; Kato S; Pinto M; Sadarangani A; Monso C; Aranda E; Villalon M; Richer JK; Horwitz KB; Brosens JJ; Owen GI
Breast Cancer Res Treat; 2005 Nov; 94(2):171-83. PubMed ID: 16175315
[TBL] [Abstract][Full Text] [Related]
26. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
So JY; Smolarek AK; Salerno DM; Maehr H; Uskokovic M; Liu F; Suh N
PLoS One; 2013; 8(1):e54020. PubMed ID: 23326564
[TBL] [Abstract][Full Text] [Related]
27. Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide.
E M Eid E; S Alanazi A; Koosha S; A Alrasheedy A; Azam F; M Taban I; Khalilullah H; Sadiq Al-Qubaisi M; A Alshawsh M
Molecules; 2019 Jul; 24(14):. PubMed ID: 31337024
[TBL] [Abstract][Full Text] [Related]
28. Zerumbone modulates CD1d expression and lipid antigen presentation pathway in breast cancer cells.
Shyanti RK; Sehrawat A; Singh SV; Mishra JPN; Singh RP
Toxicol In Vitro; 2017 Oct; 44():74-84. PubMed ID: 28633979
[TBL] [Abstract][Full Text] [Related]
29. Zerumbone inhibits migration in ESCC via promoting Rac1 ubiquitination.
Wang M; Niu J; Gao L; Gao Y; Gao S
Biomed Pharmacother; 2019 Jan; 109():2447-2455. PubMed ID: 30551505
[TBL] [Abstract][Full Text] [Related]
30. Zerumbone binding to estrogen receptors: an in-silico investigation.
Eid EEM; Azam F; Hassan M; Taban IM; Halim MA
J Recept Signal Transduct Res; 2018 Aug; 38(4):342-351. PubMed ID: 30396310
[TBL] [Abstract][Full Text] [Related]
31. CD146, a novel target of CD44-signaling, suppresses breast tumor cell invasion.
Ouhtit A; Abdraboh ME; Hollenbach AD; Zayed H; Raj MHG
Cell Commun Signal; 2017 Nov; 15(1):45. PubMed ID: 29121955
[TBL] [Abstract][Full Text] [Related]
32. Zerumbone-incorporated liquid crystalline nanoparticles inhibit proliferation and migration of non-small-cell lung cancer in vitro.
Manandhar B; Paudel KR; Clarence DD; De Rubis G; Madheswaran T; Panneerselvam J; Zacconi FC; Williams KA; Pont LG; Warkiani ME; MacLoughlin R; Oliver BG; Gupta G; Singh SK; Chellappan DK; Hansbro PM; Dua K
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):343-356. PubMed ID: 37439806
[TBL] [Abstract][Full Text] [Related]
33. Logic-based analysis of gene expression data predicts association between TNF, TGFB1 and EGF pathways in basal-like breast cancer.
Jo K; Santos-Buitrago B; Kim M; Rhee S; Talcott C; Kim S
Methods; 2020 Jul; 179():89-100. PubMed ID: 32445696
[TBL] [Abstract][Full Text] [Related]
34. C-C motif chemokine receptor 1 (CCR1) is a target of the EGF-AKT-mTOR-STAT3 signaling axis in breast cancer cells.
Shin SY; Lee DH; Lee J; Choi C; Kim JY; Nam JS; Lim Y; Lee YH
Oncotarget; 2017 Nov; 8(55):94591-94605. PubMed ID: 29212252
[TBL] [Abstract][Full Text] [Related]
35. Cellular and molecular antiproliferative effects in 2D monolayer and 3D-cultivated HT-29 cells treated with zerumbone.
de Oliveira Silva N; de Lima LVA; de Oliveira LM; da Silva MF; de Aguiar AP; Semprebon SC; Favaron PO; Lepri SR; Felicidade I; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1561-1573. PubMed ID: 37672080
[TBL] [Abstract][Full Text] [Related]
36. Differential mRNA expression in the induction of DNA damage, G
Rondina DBL; de Lima LVA; da Silva MF; Zanetti TA; Felicidade I; Marques LA; Coatti GC; Mantovani MS
Toxicol In Vitro; 2022 Dec; 85():105474. PubMed ID: 36122806
[TBL] [Abstract][Full Text] [Related]
37. Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway.
Qiu L; Ma Y; Chen X; Zhou L; Zhang H; Zhong G; Zhang L; Tang J
J Transl Med; 2021 Aug; 19(1):344. PubMed ID: 34376200
[TBL] [Abstract][Full Text] [Related]
38. [Advances on anti-tumor mechanisms of zerumbone].
Yang H; Dou RM; Yao T; Gui DP; Jang XW; Li JJ; Ge FX; Gao XL; Chai XY
Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(12):2817-2826. PubMed ID: 32627455
[TBL] [Abstract][Full Text] [Related]
39. Zerumbone inhibits melanoma cell proliferation and migration by altering mitochondrial functions.
Yan H; Ren MY; Wang ZX; Feng SJ; Li S; Cheng Y; Hu CX; Gao SQ; Zhang GQ
Oncol Lett; 2017 Apr; 13(4):2397-2402. PubMed ID: 28454410
[TBL] [Abstract][Full Text] [Related]
40. CD44 in Ovarian Cancer Progression and Therapy Resistance-A Critical Role for STAT3.
Martincuks A; Li PC; Zhao Q; Zhang C; Li YJ; Yu H; Rodriguez-Rodriguez L
Front Oncol; 2020; 10():589601. PubMed ID: 33335857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
